Over 90 Total Lots Up For Auction at One Location - WA 04/08

Pandemic a Boon for Protein Sciences

by Lynn Shapiro, Writer | July 01, 2009

HHS decided that Protein Sciences is a healthy enough company to make the vaccine, despite the near-bankruptcy, Adams says.

Patents Are Strong

Adams says the company's patents are very strong, centered on cell lines that can be approved for commercialization by the FDA.

"The strength of the patents prevents rivals from competing. They are five to 10 years away [from making their own recombinant product]," Adams says.

He says, "The big guys tried to ignore us for a long time and they can't do that anymore. We are in constant contact with all the big vaccine makers."

Read More on DOTmed.com
DNA-based Influenza Vaccine Will Be Made by Protein Sciences, Government Says
https://www.dotmed.com/news/story/9502

Novartis First to Make H1N1 Vaccine Using New Cell Technology
https://www.dotmed.com/news/story/9338/

WHO Declares Swine Flu Pandemic
https://www.dotmed.com/news/story/9330/

Flu Slowing in Most Parts of U.S; Vaccine Makers Get $1 Billion
https://www.dotmed.com/news/story/9198/

Swine Flu Virus Update--Where We Stand and How We Got Here
https://www.dotmed.com/news/story/9020/

Delicate Balance of Life on Earth Revealed in Current Flu Spread
https://www.dotmed.com/news/story/9017/

CDC Must Decide Whether to Ramp up New Flu Vaccine
https://www.dotmed.com/news/story/8975/

Race to Find a Flu Vaccine Is On; Flu Remedies Profit
https://www.dotmed.com/news/story/8964/

All Bets Are on Drug Stocks; Government Has Ample Supply
https://www.dotmed.com/news/story/8922











Back to HCB News